BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.2878
-0.1643 (-36.34%)
Sep 5, 2025, 3:14 PM EDT
BioCorRx Market Cap
BioCorRx has a market cap or net worth of $5.45 million as of September 5, 2025. Its market cap has decreased by -60.76% in one year.
Market Cap
5.45M
Enterprise Value
7.90M
Revenue
313.14K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.29
Market Cap Chart
Since November 1, 2011, BioCorRx's market cap has increased from 2.26M to 5.45M, an increase of 140.84%. That is a compound annual growth rate of 6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 5.45M | 9.48% |
| Dec 31, 2024 | 4.98M | -26.29% |
| Dec 29, 2023 | 6.75M | -9.64% |
| Dec 30, 2022 | 7.47M | -74.20% |
| Dec 31, 2021 | 28.98M | 462.57% |
| Dec 31, 2020 | 5.15M | -64.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |